Zemvax, 80,513 Shares Net Bought by Individuals in Last 5 Days... Stock Price 24,200 Won (-5.1%)

As of 1:30 PM on the 24th, ZEMVAX is trading at 24,200 KRW, down 5.1% from the previous day. The trading volume is 868,906 shares, which is 63.28% of the previous day's volume. ZEMVAX is known as a manufacturer of contamination control equipment for the semiconductor and display sectors.

On September 21, researcher Oh Byung-yong from Hanyang Securities stated, "1) The full data from Phase 2 clinical trials and research results on the mechanism of action are scheduled to be published in a paper soon, 2) Around October, a clinical trial plan and conditional marketing authorization application for domestic Phase 3 clinical trials will be submitted. Additionally, 3) the expansion of the US clinical protocol is currently under discussion with the FDA, and the results of this consultation will be announced soon. Bio stocks attract market attention only when there are events. ZEMVAX has finally reached a point where multiple events are converging. The stock price has not risen relatively much. It is a good time to buy." He set ZEMVAX's target price at 45,000 KRW.

Over the past five days, individual investors have net purchased 80,513 shares of ZEMVAX, while foreigners and institutions have net sold 49,139 shares and net purchased 30,155 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.